Congress tradeDisclosed 23 days after the transaction; reported as an official range, not an exact amount.
Loading…
PODD · NASDAQ · Health Care Equipment
Health Care Equipment company based in Acton, Massachusetts.
Last close, Oct 1, 2026
$130.79
Adjusted for splits and dividends
Last 12 months
-57.3%
S&P 500 +14.3% over the same dates
Market value
$9.07B
Last close × shares outstanding
Bets against the stock: 5.08M shares sold short (7.3% of shares outstanding), +14.3% vs the previous count, 3.1 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$2.71B
+30.7% vs the year before
Net income, fiscal 2025
$247M
As reported in the annual filing
Shares outstanding
69.4M
As of Jul 29, 2026
In fiscal 2025 the company spent $59.6M buying back its own shares. Cash actually paid, from its cash-flow statement.
Disclosed 23 days after the transaction; reported as an official range, not an exact amount.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Stock since the trade -8.7% · S&P 500 +1.3% · to Oct 1Traded 28 days after resultsStock within 1% of its 52-week low, after a 25% drop in the previous month
6,251 → 9,041 shares held+45% of their stake
A board member of Insulet Corporation spent $400K of their very own money to buy Insulet Corporation shares. 1 other person at Insulet Corporation bought some too, in the same month. It was the first time in 6 months that they bought.
Stock since the trade -8.7% · S&P 500 +1.3% · to Oct 1Traded 28 days after resultsStock within 1% of its 52-week low, after a 25% drop in the previous month
4,747 → 4,329 shares held−9% of their stake
A board member of Insulet Corporation sold $60K of Insulet Corporation shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
A securities lawsuit naming the company as a defendant was filed on Jul 2, 2026 in the U.S. District Court, D. Massachusetts. A filing is an allegation, not a finding.
In re Insulet Corporation Securities Litigation, 1:26-cv-13062Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
Short sale volume: 45.8% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 48.1%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
2 approvals or clearances and 4 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
11 certified in FY2026 Q3, vs 11 a year earlier. 11 positions in total, median offered wage $150K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Last 12 months, adjusted daily closes
Adjusted close went from $305.98 on Oct 1, 2025 to $130.79 on Oct 1, 2026 (-57.3%). Disclosed trades in the last 12 months: 5 insider purchases, 2 insider sales, 1 Congress purchase, 2 Congress sales. 2 groups of purchases by several insiders within a few days.
Changed auditor
8-K/A on sec.govTop officer leaving
“Board Resignation In connection with her appointment as Executive Vice President and Chief Financial Officer, Ms.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.